Pharma Journalist - Page 573 of 924 -

Roche Acquires PathAI to Expand Digital Pathology Business

Altasciences, Certara Partner to Speed Early Drug Development

Angelini Pharma to Acquire Catalyst in $4.1 Billion Deal

RNA Targeted Small Molecules: Finally Drug the “Undruggable” RNA

Mike Page, Alexion Pharmaceuticals invite to SMi’s Orphan Drugs & Rare Diseases Conference

Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India

EC approves Roche’s Tecentriq in combination with Abraxane for people with PD-L1-positive, metastatic triple-negative breast cancer

Anifrolumab Phase III trial meets primary endpoint in systemic lupus erythematosus

AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development Program

Esperion’s Bempedoic Acid/ Ezetimibe Tablet Achieves Positive Phase II Results

La Jolla Pharmaceutical Company Receives European Commission Approval for GIAPREZA (angiotensin II)

PCI Strengthens Position in Europe with Investment in Ireland

Immatics and Celgene Enter Strategic Collaboration to Develop Novel Adoptive Cell Therapies